 |
PDBsum entry 2a07
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription/DNA
|
PDB id
|
|
|
|
2a07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transcription/DNA
|
 |
|
Title:
|
 |
Crystal structure of foxp2 bound specifically to DNA.
|
|
Structure:
|
 |
5'-d( Ap Ap Cp Tp Ap Tp Gp Ap Ap Ap Cp Ap Ap Ap Tp Tp Tp Tp Cp Cp T)-3'. Chain: a, c. Engineered: yes. Other_details: promoter element of a foxp regulated gene, plus strand. 5'-d( Tp Tp Ap Gp Gp Ap Ap Ap Ap Tp Tp Tp Gp Tp Tp Tp Cp Ap Tp Ap G)-3'. Chain: b, d.
|
|
Source:
|
 |
Synthetic: yes. Other_details: DNA is synthesized by solid phase method. Homo sapiens. Human. Organism_taxid: 9606. Gene: foxp2, cagh44, tnrc10. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Biol. unit:
|
 |
Decamer (from
)
|
|
Resolution:
|
 |
|
1.90Å
|
R-factor:
|
0.222
|
R-free:
|
0.244
|
|
|
Authors:
|
 |
J.C.Stroud,Y.Wu,D.L.Bates,A.Han,K.Nowick,S.Paabo,H.Tong,L.Chen
|
Key ref:
|
 |
J.C.Stroud
et al.
(2006).
Structure of the forkhead domain of FOXP2 bound to DNA.
Structure,
14,
159-166.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
16-Jun-05
|
Release date:
|
31-Jan-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
O15409
(FOXP2_HUMAN) -
Forkhead box protein P2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
715 a.a.
82 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
|
|
|
|
|
A-A-C-T-A-T-G-A-A-A-C-A-A-A-T-T-T-T-C-C-T
21 bases
|
|
|
|
T-T-A-G-G-A-A-A-A-T-T-T-G-T-T-T-C-A-T-A-G
21 bases
|
|
|
|
A-A-C-T-A-T-G-A-A-A-C-A-A-A-T-T-T-T-C-C-T
21 bases
|
|
|
|
T-T-A-G-G-A-A-A-A-T-T-T-G-T-T-T-C-A-T-A-G
21 bases
|
|
|
 |
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
14:159-166
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of the forkhead domain of FOXP2 bound to DNA.
|
|
J.C.Stroud,
Y.Wu,
D.L.Bates,
A.Han,
K.Nowick,
S.Paabo,
H.Tong,
L.Chen.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
FOXP (FOXP1-4) is a newly defined subfamily of the forkhead box (FOX)
transcription factors. A mutation in the FOXP2 forkhead domain cosegregates with
a severe speech disorder, whereas several mutations in the FOXP3 forkhead domain
are linked to the IPEX syndrome in human and a similar autoimmune phenotype in
mice. Here we report a 1.9 A crystal structure of the forkhead domain of human
FOXP2 bound to DNA. This structure allows us to revise the previously proposed
DNA recognition mechanism and provide a unifying model of DNA binding for the
FOX family of proteins. Our studies also reveal that the FOXP2 forkhead domain
can form a domain-swapped dimer, made possible by a strategic substitution of a
highly conserved proline in conventional FOX proteins with alanine in the P
subfamily. Disease-causing mutations in FOXP2 and FOXP3 map either to the DNA
binding surface or the domain-swapping dimer interface, functionally
corroborating the crystal structure.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 6.
Figure 6. Disease Mutations (A) IPEX mutation
Ile363Val in FOXP3. The corresponding residue in FOXP2, Ile530,
forms a cascade of van der Waals interactions with Leu527,
Leu556, and Trp573 that contribute directly or indirectly to DNA
binding. (B) IPEX mutation Ala384Thr in FOXP3. The
corresponding residue Ala551 in FOXP2 on helix H3 packs
intimately against Tyr509. The Ala384Thr mutation would bring an
extra g-methyl group into a tightly packed protein/DNA interface
and disrupt DNA binding. (C) IPEX mutations Phe371Cys and
Phe371Leu in FOXP3. The corresponding residue Phe538 in FOXP2 is
critically located at the center of the domain-swapped dimer
interface. Mutations of this phenylalanine residue to Cys or
even a hydrophobic residue Leu may disrupt dimerization.
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(2006,
14,
159-166)
copyright 2006.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.S.Bandukwala,
Y.Wu,
M.Feuerer,
Y.Chen,
B.Barboza,
S.Ghosh,
J.C.Stroud,
C.Benoist,
D.Mathis,
A.Rao,
and
L.Chen
(2011).
Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells.
|
| |
Immunity,
34,
479-491.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.E.Santos,
A.Athanasiadis,
A.B.Leitão,
L.DuPasquier,
and
E.Sucena
(2011).
Alternative splicing and gene duplication in the evolution of the FoxP gene subfamily.
|
| |
Mol Biol Evol,
28,
237-247.
|
 |
|
|
|
|
 |
Y.P.Chu,
C.H.Chang,
J.H.Shiu,
Y.T.Chang,
C.Y.Chen,
and
W.J.Chuang
(2011).
Solution structure and backbone dynamics of the DNA-binding domain of FOXP1: Insight into its domain swapping and DNA binding.
|
| |
Protein Sci,
20,
908-924.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Planchart,
and
C.J.Mattingly
(2010).
2,3,7,8-Tetrachlorodibenzo-p-dioxin upregulates FoxQ1b in zebrafish jaw primordium.
|
| |
Chem Res Toxicol,
23,
480-487.
|
 |
|
|
|
|
 |
B.A.Benayoun,
S.Caburet,
A.Dipietromaria,
A.Georges,
B.D'Haene,
P.J.Pandaranayaka,
D.L'Hôte,
A.L.Todeschini,
S.Krishnaswamy,
M.Fellous,
E.De Baere,
and
R.A.Veitia
(2010).
Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).
|
| |
PLoS One,
5,
e8789.
|
 |
|
|
|
|
 |
F.J.Quintana,
A.H.Iglesias,
M.F.Farez,
M.Caccamo,
E.J.Burns,
N.Kassam,
M.Oukka,
and
H.L.Weiner
(2010).
Adaptive autoimmunity and Foxp3-based immunoregulation in zebrafish.
|
| |
PLoS One,
5,
e9478.
|
 |
|
|
|
|
 |
S.E.Lindner,
E.K.De Silva,
J.L.Keck,
and
M.Llinás
(2010).
Structural determinants of DNA binding by a P. falciparum ApiAP2 transcriptional regulator.
|
| |
J Mol Biol,
395,
558-567.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.M.Vaquerizas,
S.K.Kummerfeld,
S.A.Teichmann,
and
N.M.Luscombe
(2009).
A census of human transcription factors: function, expression and evolution.
|
| |
Nat Rev Genet,
10,
252-263.
|
 |
|
|
|
|
 |
L.Wang,
E.F.de Zoeten,
M.I.Greene,
and
W.W.Hancock
(2009).
Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells.
|
| |
Nat Rev Drug Discov,
8,
969-981.
|
 |
|
|
|
|
 |
S.Hannenhalli,
and
K.H.Kaestner
(2009).
The evolution of Fox genes and their role in development and disease.
|
| |
Nat Rev Genet,
10,
233-240.
|
 |
|
|
|
|
 |
B.A.Benayoun,
S.Caburet,
A.Dipietromaria,
M.Bailly-Bechet,
F.Batista,
M.Fellous,
D.Vaiman,
and
R.A.Veitia
(2008).
The identification and characterization of a FOXL2 response element provides insights into the pathogenesis of mutant alleles.
|
| |
Hum Mol Genet,
17,
3118-3127.
|
 |
|
|
|
|
 |
B.Zhou,
Q.Zhong,
P.Minoo,
C.Li,
D.K.Ann,
B.Frenkel,
E.E.Morrisey,
E.D.Crandall,
and
Z.Borok
(2008).
Foxp2 inhibits Nkx2.1-mediated transcription of SP-C via interactions with the Nkx2.1 homeodomain.
|
| |
Am J Respir Cell Mol Biol,
38,
750-758.
|
 |
|
|
|
|
 |
C.D.Fetterman,
B.Rannala,
and
M.A.Walter
(2008).
Identification and analysis of evolutionary selection pressures acting at the molecular level in five forkhead subfamilies.
|
| |
BMC Evol Biol,
8,
261.
|
 |
|
|
|
|
 |
M.M.Brent,
R.Anand,
and
R.Marmorstein
(2008).
Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification.
|
| |
Structure,
16,
1407-1416.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Obsil,
and
V.Obsilova
(2008).
Structure/function relationships underlying regulation of FOXO transcription factors.
|
| |
Oncogene,
27,
2263-2275.
|
 |
|
|
|
|
 |
Z.Zhou,
X.Song,
B.Li,
and
M.I.Greene
(2008).
FOXP3 and its partners: structural and biochemical insights into the regulation of FOXP3 activity.
|
| |
Immunol Res,
42,
19-28.
|
 |
|
|
|
|
 |
E.Spiteri,
G.Konopka,
G.Coppola,
J.Bomar,
M.Oldham,
J.Ou,
S.C.Vernes,
S.E.Fisher,
B.Ren,
and
D.H.Geschwind
(2007).
Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain.
|
| |
Am J Hum Genet,
81,
1144-1157.
|
 |
|
|
|
|
 |
K.L.Tsai,
Y.J.Sun,
C.Y.Huang,
J.Y.Yang,
M.C.Hung,
and
C.D.Hsiao
(2007).
Crystal structure of the human FOXO3a-DBD/DNA complex suggests the effects of post-translational modification.
|
| |
Nucleic Acids Res,
35,
6984-6994.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.C.Vernes,
E.Spiteri,
J.Nicod,
M.Groszer,
J.M.Taylor,
K.E.Davies,
D.H.Geschwind,
and
S.E.Fisher
(2007).
High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders.
|
| |
Am J Hum Genet,
81,
1232-1250.
|
 |
|
|
|
|
 |
S.S.Myatt,
and
E.W.Lam
(2007).
The emerging roles of forkhead box (Fox) proteins in cancer.
|
| |
Nat Rev Cancer,
7,
847-859.
|
 |
|
|
|
|
 |
T.Yang,
H.Vidarsson,
S.Rodrigo-Blomqvist,
S.S.Rosengren,
S.Enerback,
and
R.J.Smith
(2007).
Transcriptional control of SLC26A4 is involved in Pendred syndrome and nonsyndromic enlargement of vestibular aqueduct (DFNB4).
|
| |
Am J Hum Genet,
80,
1055-1063.
|
 |
|
|
|
|
 |
W.Lin,
D.Haribhai,
L.M.Relland,
N.Truong,
M.R.Carlson,
C.B.Williams,
and
T.A.Chatila
(2007).
Regulatory T cell development in the absence of functional Foxp3.
|
| |
Nat Immunol,
8,
359-368.
|
 |
|
|
|
|
 |
A.Y.Rudensky,
M.Gavin,
and
Y.Zheng
(2006).
FOXP3 and NFAT: partners in tolerance.
|
| |
Cell,
126,
253-256.
|
 |
|
|
|
|
 |
Y.Wu,
M.Borde,
V.Heissmeyer,
M.Feuerer,
A.D.Lapan,
J.C.Stroud,
D.L.Bates,
L.Guo,
A.Han,
S.F.Ziegler,
D.Mathis,
C.Benoist,
L.Chen,
and
A.Rao
(2006).
FOXP3 controls regulatory T cell function through cooperation with NFAT.
|
| |
Cell,
126,
375-387.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |